000			02280 a2200637 4500
005			20250517105721.0
264		0	_c20171107
008			201711s 0 0 eng d
022			_a1463-1326
024	7		_a10.1111/dom.12748 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmits, Mark M
245	0	0	_aBiliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. _h[electronic resource]
260			_bDiabetes, obesity & metabolism _c12 2016
300			_a1217-1225 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aBile Acids and Salts _xmetabolism
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aChenodeoxycholic Acid _xmetabolism
650	0	4	_aCholic Acid _xmetabolism
650	0	4	_aDeoxycholic Acid _xmetabolism
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDipeptidyl-Peptidase IV Inhibitors _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFasting
650	0	4	_aFeces _xchemistry
650	0	4	_aFemale
650	0	4	_aGallbladder _xdiagnostic imaging
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aLiraglutide _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aOrgan Size
650	0	4	_aPostprandial Period
650	0	4	_aSitagliptin Phosphate _xtherapeutic use
650	0	4	_aSulfonylurea Compounds _xtherapeutic use
650	0	4	_aUltrasonography
650	0	4	_aUrsodeoxycholic Acid _xmetabolism
650	0	4	_aGlucagon-Like Peptide-1 Receptor Agonists
700	1		_aTonneijck, Lennart
700	1		_aMuskiet, Marcel H A
700	1		_aHoekstra, Trynke
700	1		_aKramer, Mark H H
700	1		_aDiamant, Michaela
700	1		_aNieuwdorp, Max
700	1		_aGroen, Albert K
700	1		_aCahen, Djuna L
700	1		_avan Raalte, Daniël H
773	0		_tDiabetes, obesity & metabolism _gvol. 18 _gno. 12 _gp. 1217-1225
856	4	0	_uhttps://doi.org/10.1111/dom.12748 _zAvailable from publisher's website
999			_c26258966 _d26258966